Tristel PLC
25 May 2006
Tristel plc
25 May 2006
Director/PDMR Shareholding
Tristel plc ('Tristel'), the healthcare business which uses its proprietary
chlorine dioxide chemistry to create infection control products for hospitals
announces the following share purchases by directors:
On 24 May 2006 Peter Stephens (Non-Executive Director) acquired 25,000 shares at
46.5 pence each, taking his total shareholding to 573,937 shares (2.4%).
ENDS
Tristel plc Parkgreen Communications Ltd
Paul Swinney, Chief Executive Paul McManus
Paul Barnes, Finance Director
Tel: 01638 721500 Tel 020 7786 9600
http://www.tristel.com Mob: 07980 541 893
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.